P3 Health Partners Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.5B | $1.5B | $1.3B | $1.0B | — |
| Operating income | -$270.3M | -$320.7M | -$167.9M | -$1.6B | — |
| Operating expenses | $1.7B | $1.8B | $1.4B | $2.6B | — |
| Cash from operations | -$91.2M | -$110.1M | -$76.0M | -$126.0M | — |
| Capital expenditure | — | $0 | $1.8M | $2.2M | — |
| Free cash flow | — | -$110.1M | -$77.9M | -$128.3M | — |
| Impairments | — | — | $0 | $1.3B | — |
| Total assets | $656.6M | $783.4M | $861.0M | $876.6M | $2.4B |
| Total liabilities | $796.9M | $633.9M | $427.3M | $353.9M | $299.9M |
| Total debt | $273.4M | $184.1M | $108.3M | $95.0M | $80.0M |
Shares outstanding 7.2M · Free float 76.0%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.